Topical Cannabis for AIMSS: Medical Cannabis Evidence-Based Care
Clinical Takeaway Topical cannabis balms were tested in a randomized open-label trial to evaluate their safety and feasibility for managing joint pain and stiffness caused by aromatase inhibitor therapy in breast cancer patients. The study found the…
Topical Cannabis for AIMSS: Medical Cannabis Evidence
Clinical Takeaway In this randomized trial, topical cannabis balms were evaluated for feasibility and tolerability in postmenopausal breast cancer patients experiencing joint pain and stiffness from aromatase inhibitor therapy. The study found that…
Topical Cannabis Balms for AIMSS: Clinical Trial Data
Clinical Takeaway Topical cannabis balms were tested in a randomized, open-label trial among postmenopausal women with hormone receptor-positive breast cancer who developed musculoskeletal pain and joint stiffness from aromatase inhibitor therapy. The…